Forsyth PA - Search Results

1

Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor‒Resistant Melanoma.

Zhang C, Smalley I, Emmons MF, Sharma R, Izumi V, Messina J, Koomen JM, Pasquale EB, Forsyth PA, Smalley KSM. Zhang C, et al. Among authors: forsyth pa. J Invest Dermatol. 2021 Apr;141(4):840-851.e4. doi: 10.1016/j.jid.2020.08.012. Epub 2020 Sep 2. J Invest Dermatol. 2021. PMID: 32890629 Free PMC article.

2

Novel treatments for melanoma brain metastases.

Kenchappa RS, Tran N, Rao NG, Smalley KS, Gibney GT, Sondak VK, Forsyth PA. Kenchappa RS, et al. Among authors: forsyth pa. Cancer Control. 2013 Oct;20(4):298-306. doi: 10.1177/107327481302000407. Cancer Control. 2013. PMID: 24077406 Free article. Review.

3

Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.

Smalley KS, Fedorenko IV, Kenchappa RS, Sahebjam S, Forsyth PA. Smalley KS, et al. Among authors: forsyth pa. Int J Cancer. 2016 Sep 15;139(6):1195-201. doi: 10.1002/ijc.30147. Epub 2016 Apr 30. Int J Cancer. 2016. PMID: 27084046 Free PMC article. Review.

4

A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.

Fedorenko IV, Evernden B, Kenchappa RS, Sahebjam S, Ryzhova E, Puskas J, McIntosh L, Caceres G, Magliocco A, Etame A, Harbour JW, Smalley KS, Forsyth PA. Fedorenko IV, et al. Among authors: forsyth pa. Melanoma Res. 2016 Oct;26(5):481-6. doi: 10.1097/CMR.0000000000000274. Melanoma Res. 2016. PMID: 27285292 Free PMC article. Review.

5

Experimental Treatments for Leptomeningeal Metastases From Solid Malignancies.

Sahebjam S, Forsyth PA, Smalley KS, Tran ND. Sahebjam S, et al. Among authors: forsyth pa. Cancer Control. 2017 Jan;24(1):42-46. doi: 10.1177/107327481702400106. Cancer Control. 2017. PMID: 28178711 Free article. Review.

6

BRAF-MEK inhibition in melanoma brain metastases: a new hope.

Forsyth PA, Smalley KSM, Sondak VK. Forsyth PA, et al. Lancet Oncol. 2017 Jul;18(7):836-837. doi: 10.1016/S1470-2045(17)30449-7. Lancet Oncol. 2017. PMID: 28677560 No abstract available.

7

Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.

Sloot S, Chen YA, Zhao X, Weber JL, Benedict JJ, Mulé JJ, Smalley KS, Weber JS, Zager JS, Forsyth PA, Sondak VK, Gibney GT. Sloot S, et al. Among authors: forsyth pa. Cancer. 2018 Jan 15;124(2):297-305. doi: 10.1002/cncr.30946. Epub 2017 Oct 12. Cancer. 2018. PMID: 29023643 Free PMC article.

8

The Blood Brain Barrier and BRAF inhibitors: Implications for patients with melanoma brain metastases.

Smalley KSM, Forsyth PA. Smalley KSM, et al. Among authors: forsyth pa. Pharmacol Res. 2018 Sep;135:265-267. doi: 10.1016/j.phrs.2017.11.013. Epub 2017 Nov 13. Pharmacol Res. 2018. PMID: 29146209 No abstract available.

9

The biology and therapeutic management of melanoma brain metastases.

Abate-Daga D, Ramello MC, Smalley I, Forsyth PA, Smalley KSM. Abate-Daga D, et al. Among authors: forsyth pa. Biochem Pharmacol. 2018 Jul;153:35-45. doi: 10.1016/j.bcp.2017.12.019. Epub 2017 Dec 24. Biochem Pharmacol. 2018. PMID: 29278675 Free PMC article. Review.

10

Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.

Sloot S, Chen YA, Zhao X, Weber JL, Benedict JJ, Mulé JJ, Smalley KS, Weber JS, Zager JS, Forsyth PA, Sondak VK, Gibney GT. Sloot S, et al. Among authors: forsyth pa. Cancer. 2018 May 15;124(10):2254-2255. doi: 10.1002/cncr.31261. Epub 2018 Mar 15. Cancer. 2018. PMID: 29543319 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters